What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His primary areas of study are Angiogenesis, Neovascularization, Cancer research, Pathology and Internal medicine.
His Angiogenesis study incorporates themes from Basic fibroblast growth factor, Immunology and Cell biology.
His biological study spans a wide range of topics, including Endothelial stem cell, Vascular endothelial growth factor A, Cornea, Endothelium and In vivo.
His Cancer research research is multidisciplinary, incorporating elements of Cancer and Angiogenic Switch.
The Immunohistochemistry research Judah Folkman does as part of his general Pathology study is frequently linked to other disciplines of science, such as Intussusceptive angiogenesis, therefore creating a link between diverse domains of science.
His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Oncology.
His most cited work include:
- Tumor Angiogenesis: Therapeutic Implications (8179 citations)
- Angiogenesis in cancer, vascular, rheumatoid and other disease (7087 citations)
- Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis (6041 citations)
What are the main themes of his work throughout his whole career to date?
Angiogenesis, Cancer research, Pathology, Internal medicine and Neovascularization are his primary areas of study.
His studies in Angiogenesis integrate themes in fields like Endothelial stem cell, Cancer, Immunology and Basic fibroblast growth factor.
Judah Folkman combines subjects such as Endothelium and Angiogenic Switch with his study of Cancer research.
His Pathology research is multidisciplinary, relying on both Tumor angiogenesis and Transplantation.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Endocrinology and Oncology.
In his study, In vitro is strongly linked to In vivo, which falls under the umbrella field of Neovascularization.
He most often published in these fields:
- Angiogenesis (50.81%)
- Cancer research (30.38%)
- Pathology (24.23%)
What were the highlights of his more recent work (between 2003-2019)?
- Angiogenesis (50.81%)
- Cancer research (30.38%)
- Internal medicine (22.24%)
In recent papers he was focusing on the following fields of study:
Judah Folkman mostly deals with Angiogenesis, Cancer research, Internal medicine, Cancer and Pathology.
His research in Angiogenesis intersects with topics in Platelet and Immunology.
His Cancer research research includes themes of Endothelial stem cell, Cell growth and Epidermal growth factor receptor.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Endocrinology, Surgery and Oncology.
His Cancer study combines topics in areas such as Surgical oncology, Disease and Chemotherapy.
His Pathology research incorporates themes from Hematology, Transcriptome and Transplantation.
Between 2003 and 2019, his most popular works were:
- Angiogenesis: an organizing principle for drug discovery? (1835 citations)
- Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet α granules and differentially released (655 citations)
- Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. (511 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Judah Folkman focuses on Angiogenesis, Cancer research, Cancer, Immunology and Internal medicine.
His study in Angiogenesis is interdisciplinary in nature, drawing from both Tumor progression, Angiogenic Switch and Pathology.
His research integrates issues of Endothelial stem cell and Epidermal growth factor receptor in his study of Cancer research.
He has included themes like Bevacizumab, Glioma, Angiostatin, Sunitinib and Growth factor receptor in his Immunology study.
The study incorporates disciplines such as Endocrinology and Oncology in addition to Internal medicine.
As part of the same scientific family, he usually focuses on Neovascularization, concentrating on Angiogenesis inhibitor and intersecting with Cell biology, Stromal cell and Bone marrow.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
